Results 91 to 100 of about 14,740 (197)

Cerebral blood flow in Alzheimer’s disease

open access: yesVascular Health and Risk Management, 2012
Alex E Roher,1 Josef P Debbins,2 Michael Malek-Ahmadi,3 Kewei Chen,4 James G Pipe,2 Sharmeen Maze,2 Christine Belden,3 Chera L Maarouf,1 Pradeep Thiyyagura,4 Hua Mo,4 Jesse M Hunter,1 Tyler A Kokjohn,1,5 Douglas G Walker,6 Jane C Kruchowsky,6 Marek ...
Roher AE   +16 more
doaj  

Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies. [PDF]

open access: yesWorld J Diabetes
Suresh MG   +11 more
europepmc   +1 more source

The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance-A Systematic Review. [PDF]

open access: yesOncol Res
Mozga K   +6 more
europepmc   +1 more source

The Anti-SLAMF7 Antibody, Elotuzumab, Induces Antibody-Dependent Cellular Cytotoxicity Against CLL Cell Lines. [PDF]

open access: yesMolecules
Kľoc D   +8 more
europepmc   +1 more source

Widespread Emissions of Polychlorinated Biphenyls from Building Materials in Vermont Schools. [PDF]

open access: yesEnviron Sci Technol
Hua JBX   +5 more
europepmc   +1 more source

[Marek's disease].

open access: yesVoprosy virusologii, 1973
E S, Voronin   +2 more
openaire   +1 more source

Impact of Prior Chronic Kidney Disease and Newly Detected eGFR Impairment at Admission on Outcomes and Prognosis of Hospitalized COVID-19 Patients – A Single-Center Cohort Study

open access: yesInternational Journal of General Medicine
Michał Kania,1,2 Michał Terlecki,2,3 Krzysztof Batko,2 Marek Rajzer,2,3 Maciej T Malecki,1,2 Marcin Krzanowski2,4 1Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland; 2University Hospital, Krakow ...
Kania M   +5 more
doaj  

Home - About - Disclaimer - Privacy